.Attribute Medicine, Published online: 30 July 2024 doi:10.1038/ d41591-024-00054-wThe antitoxin-- medication conjugate (ADC) tisotumab vedotin caused strengthened progression-free and also general survival, bring about FDA approval and also a brand new procedure choice for patients.